- Home
- IMNN vs IHT Comparison
IMNN vs IHT Comparison
Compare IMNN & IHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- IHT
- Stock Information
- Founded
- IMNN 1982
- IHT 1971
- Country
- IMNN United States
- IHT United States
- Employees
- IMNN N/A
- IHT N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- IHT Investment Bankers/Brokers/Service
- Sector
- IMNN Health Care
- IHT Finance
- Exchange
- IMNN Nasdaq
- IHT Nasdaq
- Market Cap
- IMNN 12.9M
- IHT 12.6M
- IPO Year
- IMNN 1985
- IHT N/A
- Fundamental
- Price
- IMNN $3.77
- IHT $1.29
- Analyst Decision
- IMNN Buy
- IHT
- Analyst Count
- IMNN 2
- IHT 0
- Target Price
- IMNN $182.61
- IHT N/A
- AVG Volume (30 Days)
- IMNN 56.4K
- IHT 39.7K
- Earning Date
- IMNN 11-13-2025
- IHT 12-15-2025
- Dividend Yield
- IMNN N/A
- IHT 1.54%
- EPS Growth
- IMNN N/A
- IHT N/A
- EPS
- IMNN N/A
- IHT N/A
- Revenue
- IMNN N/A
- IHT $7,463,789.00
- Revenue This Year
- IMNN N/A
- IHT N/A
- Revenue Next Year
- IMNN N/A
- IHT N/A
- P/E Ratio
- IMNN N/A
- IHT N/A
- Revenue Growth
- IMNN N/A
- IHT N/A
- 52 Week Low
- IMNN $3.56
- IHT $1.26
- 52 Week High
- IMNN $41.22
- IHT $4.24
- Technical
- Relative Strength Index (RSI)
- IMNN 35.44
- IHT 32.82
- Support Level
- IMNN $3.56
- IHT $1.26
- Resistance Level
- IMNN $4.38
- IHT $1.50
- Average True Range (ATR)
- IMNN 0.30
- IHT 0.07
- MACD
- IMNN 0.00
- IHT -0.01
- Stochastic Oscillator
- IMNN 21.95
- IHT 10.00
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.